Table 3. Summary of number of deaths .... | American Society of Hematology

Table 3.

Summary of number of deaths

	Weeks on/off treatment, by dosage
	4/2			4/1
	50 mg	75 mg	50 mg	Total
No. deaths on study occurring no more than 30 days from stoppage of treatment	6	2	3	11
No. deaths on follow-up	1	0	1	2
Cause of death, no.
Infection	2	1	2	5
Leukocytosis	3*	0	1	4
Bleeding	1	0	1	4
Myocardial infarction	1	0	0	1
Cardiac insufficiency	0	1†	0	1

	Weeks on/off treatment, by dosage
	4/2			4/1
	50 mg	75 mg	50 mg	Total
No. deaths on study occurring no more than 30 days from stoppage of treatment	6	2	3	11
No. deaths on follow-up	1	0	1	2
Cause of death, no.
Infection	2	1	2	5
Leukocytosis	3*	0	1	4
Bleeding	1	0	1	4
Myocardial infarction	1	0	0	1
Cardiac insufficiency	0	1†	0	1

Two of the deaths occurred in follow-up.

Considered possibly related to the drug, on cycle 2.